Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shruti D. Shah"'
Autor:
Shruti D. Shah, Bryan M. Gillard, Michelle M. Wrobel, Ellen Karasik, Michael T. Moser, Michalis Mastri, Mark D. Long, Norbert Sule, Craig M. Brackett, Wendy J. Huss, Barbara A. Foster
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionBladder cancer is a heterogenous disease and the emerging knowledge on molecular classification of bladder tumors may impact treatment decisions based on molecular subtype. Pre-clinical models representing each subtype are needed to test
Externí odkaz:
https://doaj.org/article/4ca92263d3fb4dc7be3b998b093ff868
Autor:
Shruti D Shah, Bryan M Gillard, Michelle M Wrobel, Ellen Karasik, Michael T Moser, Michalis Mastri, Norbert Sule, Craig M Brackett, Wendy J Huss, Barbara A Foster
BackgroundBladder cancer is a heterogenous disease and the emerging knowledge on molecular classification of bladder tumors could have impact to drive treatment decisions based on molecular subtype. Pre-clinical models representing each subtype are n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8a504ed4d073fb5344dd75d40acf91c
https://doi.org/10.1101/2022.12.03.518865
https://doi.org/10.1101/2022.12.03.518865
Publikováno v:
National Journal of Community Medicine, Vol 9, Iss 08 (2018)
Background Urinary Tract Infection (UTI) is common illness in- volving all age groups. Diabetics tend to have more episodes of illness as compared to non diabetics. Present study compared various epidemiological aspects of UTI among diabetic and non
Externí odkaz:
https://doaj.org/article/babbcef6e1e94e068fada388b29b2b40
Autor:
Michalis, Mastri, Swathi, Ramakrishnan, Shruti D, Shah, Ellen, Karasik, Bryan M, Gillard, Michael T, Moser, Bailey K, Farmer, Gissou, Azabdaftari, Gurkamal S, Chatta, Anna, Woloszynska, Kevin H, Eng, Barbara A, Foster, Wendy J, Huss
Publikováno v:
Am J Clin Exp Urol
The evolving paradigm of the molecular classification of bladder cancer requires models that represent the classifications with less heterogeneity. Robust transcriptome based molecular classifications are essential to address tumor heterogeneity. Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d3995dc46fb74fe3ca1570781c1a68d8
https://europepmc.org/articles/PMC8727788/
https://europepmc.org/articles/PMC8727788/
Autor:
Michelle Wrobel, Michael T. Moser, Barbara A. Foster, Shruti D. Shah, Bryan Gillard, Ellen Karasik
Publikováno v:
Clinical Cancer Research. 26:A11-A11
Immunologically, MIBC tumors can be divided into inflamed and noninflamed phenotype. Inflamed tumors show high immune cell infiltration. In contrast, noninflamed tumors have little to no immune infiltration. Clinical evidence shows that response to t
Publikováno v:
Clinical Cancer Research. 26:A10-A10
Muscle-invasive bladder cancer (MIBC) is an aggressive disease with limited treatment options. Checkpoint inhibitors, although approved as second-line therapy, have limited response rate that is indicative of intrinsic resistance to immune therapy. E
Autor:
Mohit Butaney, Melissa M. Messineo, Cam Anh Tran, Amanda J. Redig, Allison O'Connell, Antonio Calles, Sangeetha Palakurthi, Cloud P. Paweletz, Pasi A. Jänne, Shruti D. Shah, Jihyun Choi, Mosab Ali, Yanan Kuang, Masahiko Yanagita, Paul Kirschmeier, Prafulla C. Gokhale, Man Xu, Atsuko Ogino
Publikováno v:
Cancer Research. 75:1451-1451
Background: Genotype directed treatment is the standard of care for patients with advanced non-small cell lung cancer (NSCLC). However, acquired drug resistance invariably develops. There is a need to develop clinically relevant animal models from pa